glp 1 average weight loss GLP-1R Agonists for GLP-1 and weight loss injections

CMS GLP-1 Bridge Program: Medicare Part D coverage for weight-loss GLP-1 drugs starting July 1, 2026, including eligibility, covered medications, prior authorization, and copay rules.

Novo Nordisk, the manufacturer of Ozempic, announced a plan to reduce its global workforce by approximately 9,000 positions today.

Clinical trials are gold standard but they're also controlled, time-limited, and built around statistical averages

Compare 5 ways to save on Synjardy XR with or without insurance

WuXi Biology examines the potential of GLP-1 RAs in MASH treatment, exploring their mechanisms of action and evaluation strategies.